The European Union’s executive branch has commenced legal action against AstraZeneca for breaching the terms of its contract with the EU. It holds AstraZeneca responsible for partly delaying their vaccine rollout.
AstraZeneca’s contract with the EU, signed last August, foresaw an initial 300 million doses for distribution among member countries, with an option for a further 100 million.
AstraZeneca had hoped to deliver 80 million doses in the first quarter of 2021, but only 30 million were sent. According to the EU, the company is now set to provide 70 million doses in the second quarter, rather than the 180 million it had promised.
AstraZeneca said in a statement that it “regrets” the commission’s decision to take legal action and it will “strongly defend” itself in court.
Suffering a dispute can have serious implications on you and your livelihood and reputation. Our dispute resolution solicitors will quickly and efficiently put your case together and act on your behalf. Call Vijay Srivastava or Shalish Mehta in our civil and commercial litigation department on 0161 624 6811or email email@example.com or firstname.lastname@example.org. We can advise you on the appropriate course of action and assist with any legal documents or proceedings that may occur.
Latest posts by Shalish Mehta (see all)
- Former BrewDog staff accuse craft beer firm of bullying at the workplace - 24th June 2021
- Competition and Markets Authority launches action against British Airways and Ryanair - 14th June 2021
- Personal Injury Reforms 2021 - 6th June 2021
- Lidl loses trademark battle over Hendrick’s gin lookalike - 28th May 2021
- Epic Games v Apple Trial - 28th May 2021